Duoeez LD
Composition: Each 2.5 mL respule contains: Levosalbutamol Sulphate IP , equivalent to Levosalbutamol 0.63 mg Ipratropium Bromide IP , equivalent to Ipratropium 500 mcg Isotonic/normal saline solution – q.s. Preservative-free Dosage Form: Respirator / Inhalation Solution Strength: 0.63 mg + 500 mcg / 2.5 mL Route: Inhalation by nebulization Pack Size: 4 × 5 × 2.5 mL The 0.63 mg + 500 mcg combination is commercially used as a low-dose levalbuterol/ipratropium nebulization formulation.
DUOEEZ LD Respules is a preservative-free nebulization solution containing Levosalbutamol 0.63 mg and Ipratropium Bromide 500 mcg in a convenient 2.5 mL unit-dose respule. The combination provides complementary bronchodilator action through β₂-adrenergic stimulation and muscarinic receptor blockade, helping relieve bronchoconstriction and improve airflow.
The lower dose of Levosalbutamol makes DUOEEZ LD a suitable physician-directed option when a lower β₂-agonist dose is considered appropriate.
Overview
DUOEEZ LD Respules combines two bronchodilators with complementary mechanisms:
- Levosalbutamol 0.63 mg — a selective β₂-adrenergic agonist that promotes relaxation of bronchial smooth muscle.
- Ipratropium Bromide 500 mcg — an anticholinergic bronchodilator that inhibits cholinergic-mediated bronchoconstriction.
Together, these agents provide dual-mechanism bronchodilation and may help improve airflow in patients with bronchoconstrictive/obstructive airway conditions when this combination is prescribed.
Clinical positioning
DUOEEZ LD → Low-dose dual bronchodilation → Levosalbutamol + Ipratropium
Key Benefits
Low-Dose Dual Bronchodilation
Combines Levosalbutamol 0.63 mg + Ipratropium Bromide 500 mcg to provide bronchodilation through two complementary pathways.
Complementary Mechanisms
Levosalbutamol stimulates β₂ receptors to relax bronchial smooth muscle, while Ipratropium blocks muscarinic-mediated bronchoconstriction.
Helps Relieve Bronchoconstriction
The combination can help reduce airway narrowing and improve airflow when prescribed for an appropriate obstructive airway condition.
Lower Levosalbutamol Strength
DUOEEZ LD contains 0.63 mg Levosalbutamol, compared with 1.25 mg in DUOEEZ, providing a lower-dose option within the same dual-bronchodilator combination.
Preservative-Free
The formulation is supplied as a preservative-free inhalation solution, as indicated on the product pack.
Convenient Unit-Dose Respules
Each 2.5 mL respule provides a measured dose and is intended for single use.
Indications / Uses
DUOEEZ LD may be prescribed for:
- Relief of reversible bronchoconstriction
- Obstructive airway conditions requiring combined β₂-agonist + anticholinergic bronchodilation
- Patients for whom a lower Levosalbutamol dose is considered appropriate
- Physician-directed nebulized bronchodilator therapy
DUOEEZ LD should be used only according to the treating physician's clinical assessment and prescribed dosage.